Springer Nature Plans Initial Public Offering

Springer Nature AG & Co. KGaA, a global research, health, and education publisher, is preparing for an initial public offering (IPO) on the Frankfurt Stock Exchange. The IPO is expected to be completed by the end of 2024, depending on market conditions.

The offering will consist of a €200 million capital increase and the sale of existing shares held by BC Partners. Holtzbrinck Publishing Group, a majority owner, does not plan to sell its shares. The company plans to pay a €25 million dividend for the 2024 fiscal year.

Springer Nature boasts a robust financial profile with revenues of €1.85 billion and an operating profit of €511 million in 2023. The company is a leader in the research publishing market, driven by trends like Open Access and Artificial Intelligence.

Technology is a core focus for Springer Nature, with significant investments in digital initiatives. The company aims to leverage technology further to drive value and productivity. This aligns with its mission to serve the global research community.

JP Morgan, Deutsche Bank, and Morgan Stanley are among the advisors for this IPO. Springer Nature looks forward to using the proceeds to optimize its financial structure and continue its growth trajectory.